| Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients (NCT05672654) | University Hospital, Ghent | 2021-05-10 |
| Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects (NCT04408950) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-11-12 |
| Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19) (NCT04553705) | Beni-Suef University | 2020-09-20 |
| Immunodeficiency in MS (NCT04447937) | Advanced Neurosciences Institute | 2020-06-29 |
| European Alpha-Mannosidosis Participant (NCT03651245) | CENTOGENE GmbH Rostock | 2018-08-20 |
| Immunodeficiency for Severe Epstein-Barr Virus Infection (NCT03374566) | Children's Hospital of Fudan University | 2017-12-01 |
| Testing a Novel Dairy Protein to Counteract Immunosenescence (NCT03557463) | University of California, Davis | 2016-08-01 |
| Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients (NCT02651376) | Beijing 302 Hospital | 2015-09-01 |
| Blood Samples to Identify Biomarkers of Busulfan (NCT02291965) | Fred Hutchinson Cancer Center | 2014-11-01 |
| Expanded Access Protocol Thymus Transplantation (NCT02274662) | Sumitomo Pharma Switzerland GmbH | 2014-08-01 |
| Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations (NCT01861106) | National Cancer Institute (NCI) | 2013-07-24 |
| Susceptibility to Infections in Ataxia Telangiectasia (NCT02345135) | Johann Wolfgang Goethe University Hospital | 2012-09-01 |
| Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation (NCT01800643) | Hospital Israelita Albert Einstein | 2010-03-01 |
| Donor Lymphocyte Infusion After Alternative Donor Transplantation (NCT01027702) | Wake Forest University Health Sciences | 2009-08-01 |
| Epigenetic Markers of B-Cell Function in Low Birth Weight Infants (NCT00925925) | University of Utah | 2009-06-01 |
| Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC (NCT00923364) | National Cancer Institute (NCI) | 2009-05-07 |
| Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages (NCT00758992) | St. Jude Children's Research Hospital | 2006-10-01 |